Nisa Investment Advisors’s Aerie Pharmaceuticals AERI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-739
| Closed | -$11K | – | 2799 |
|
|
2022
Q3 | $11K | Buy |
739
+39
| +6% | +$453 | ﹤0.01% | 2178 |
|
|
2022
Q2 | $5K | Sell |
700
-22,000
| -97% | -$155K | ﹤0.01% | 2281 |
|
|
2022
Q1 | $207K | Buy |
22,700
+22,000
| +3,143% | +$170K | ﹤0.01% | 1366 |
|
|
2021
Q4 | $5K | Sell |
700
-7,883
| -92% | -$82.5K | ﹤0.01% | 2102 |
|
|
2021
Q3 | $98 | Buy |
8,583
+7,883
| +1,126% | +$115K | ﹤0.01% | 1716 |
|
|
2021
Q2 | $11 | Hold |
700
| – | – | ﹤0.01% | 2221 |
|
|
2021
Q1 | $13 | Hold |
700
| – | – | ﹤0.01% | 2184 |
|
|
2020
Q4 | $9K | Sell |
700
-6,347
| -90% | -$76.7K | ﹤0.01% | 2229 |
|
|
2020
Q3 | $83K | Buy |
7,047
+6,697
| +1,913% | +$81.6K | ﹤0.01% | 1603 |
|
|
2020
Q2 | $5K | Sell |
350
-950
| -73% | -$14.1K | ﹤0.01% | 2015 |
|
|
2020
Q1 | $18K | Buy |
1,300
+140
| +12% | +$2.66K | ﹤0.01% | 1726 |
|
|
2019
Q4 | $28K | Sell |
1,160
-8,180
| -88% | -$169K | ﹤0.01% | 1641 |
|
|
2019
Q3 | $180K | Buy |
9,340
+9,130
| +4,348% | +$209K | ﹤0.01% | 1349 |
|
|
2019
Q2 | $6K | Hold |
210
| – | – | ﹤0.01% | 1876 |
|
|
2019
Q1 | $10K | Hold |
210
| – | – | ﹤0.01% | 1768 |
|
|
2018
Q4 | $8K | Hold |
210
| – | – | ﹤0.01% | 1710 |
|
|
2018
Q3 | $13K | Hold |
210
| – | – | ﹤0.01% | 1658 |
|
|
2018
Q2 | $14K | Hold |
210
| – | – | ﹤0.01% | 1632 |
|
|
2018
Q1 | $11K | Sell |
210
-50
| -19% | -$2.8K | ﹤0.01% | 1640 |
|
|
2017
Q4 | $16K | Hold |
260
| – | – | ﹤0.01% | 1611 |
|
|
2017
Q3 | $13K | Hold |
260
| – | – | ﹤0.01% | 1675 |
|
|
2017
Q2 | $14K | Buy |
260
+100
| +63% | +$4.66K | ﹤0.01% | 1605 |
|
|
2017
Q1 | $7K | Sell |
160
-140
| -47% | -$6.24K | ﹤0.01% | 1770 |
|
|
2016
Q4 | $11K | Sell |
300
-300
| -50% | -$11.3K | ﹤0.01% | 1792 |
|
|
2016
Q3 | $23K | Hold |
600
| – | – | ﹤0.01% | 1613 |
|
|
2016
Q2 | $11K | Hold |
600
| – | – | ﹤0.01% | 1783 |
|
|
2016
Q1 | $7K | Buy |
+600
| New | +$9.49K | ﹤0.01% | 1824 |
|
Nisa Investment Advisors's AERI Position: Q4 2022 in Review
Nisa Investment Advisors sold out of Aerie Pharmaceuticals (AERI) in Q4 2022, closing a stake of 739 shares — an estimated $11K sold.
Nisa Investment Advisors first reported a position in AERI in Q1 2016 and held it in 27 quarters. The position peaked at $207K in Q1 2022. 0 funds tracked by Wall St. Rank hold AERI as of Q4 2022.
- Nisa Investment Advisors reported no remaining Aerie Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
- Nisa Investment Advisors sold 739 Aerie Pharmaceuticals shares in Q4 2022, an estimated $11K.
- Nisa Investment Advisors first reported a position in Aerie Pharmaceuticals in Q1 2016 and held it in 27 quarters.
- Nisa Investment Advisors's Aerie Pharmaceuticals position peaked at $207K in Q1 2022.
- 0 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2022.
Based on Nisa Investment Advisors's 13F filing for Q4 2022, filed 2 Feb 2023.